ALLO vs AON · rev $22.0K vs P/E 31, rev $17.18B
Allogene Therapeutics Inc (ALLO) versus Aon PLC (AON) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Aon PLC (AON) is a insurance brokers company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported AON revenue for 2025-12-31 was $17.18B. Net income was $3.69B. Revenue was up 9.4% from 2024-12-31 to 2025-12-31. AON currently screens at market cap $76.61B and trailing P/E 30.7.
ALLO currently screens at market cap $258.1M. AON currently screens at market cap $76.61B and trailing P/E 30.7.
Not investment advice. Open the ALLO and AON stock pages for the full models.
Not investment advice.